Evidence map›Paper›PMID 22526156›Full record

ArticleJournal of cancer research and clinical oncology2012

EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma.

Yongfeng Yu, Zhengbo Song, Hui Gao, Lei Zhu, Shun Lu, Jie Zhang, Qingquan Luo

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeted therapy for rare lung cancers: Status, challenges, and prospects.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  5. Review
  6. Article
  7. Photodynamic therapy for pulmonary mucoepidermoid carcinoma.Respiratory medicine case reports · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Primary mucoepidermoid carcinoma of the lung with prominent clear cells.Proceedings (Baylor University. Medical Center) · 2017
    Article
  12. Review
  13. [Mucoepidermoid Carcinoma of the Lung: Report of 29 Cases].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017
    Article
  14. Article
  15. Review
  16. Article
  17. Mucoepidermoid carcinoma of lung masquerading as urothelial carcinoma of bladder.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2014
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yongfeng YuShanghai Lung Cancer Center, Chest Hospital Affiliated to Shanghai Jiaotong University, 241 West Huaihai Road, Xuhui District, Shanghai 200030, China.
Zhengbo Song
Hui Gao
Lei Zhu
Shun Lu
Jie Zhang
Qingquan Luo
Shanghai Chest Hospital · CNBlood Center of Zhejiang Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to assess the feasibility of targeted treatment for pulmonary mucoepidermoid carcinoma (PMEC) by investigating track record of the epidermal growth factor receptor (EGFR) mutation status in PMEC.

methodsFrom January 2001 to December 2009, 20 PMEC patients (11 males and 9 females) received treatment in our center. All the patients received surgery and were diagnosed by pathology. Sequencing analysis was used to monitor exons 18-21 of the EGFR gene mutation.

resultsThe exon 21 L861Q heterozygous mutation was confirmed in five patients. There was no case with any deletion in exon 19 or exon 21 L858R mutation. One case was with a homonymy exon 18 mutation (I760I). Exon 20 G2607A (Q787Q) SNP was found in 12 of those 20 patients.

conclusionL861Q mutation in exon 21 is the most frequent feature of heterozygous mutation in our study. Further investigations will be required to validate our findings.

Indexed as

MutationAdolescentAdultAgedAmino Acid SubstitutionBase SequenceCarcinoma, MucoepidermoidChildDNA Mutational AnalysisErbB ReceptorsExonsFeasibility StudiesFemaleHeterozygoteHumansLung NeoplasmsErbB Receptors

Identifiers

PMID22526156
PMCPMC11824773
OpenAlexW2031629812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.